Comparing lithium and cariprazine for treating bipolar depression

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to compare the effectiveness of lithium and cariprazine in treating patients with bipolar disorder who are experiencing a depressive episode. Participants will be randomly assigned to receive either lithium or cariprazine for eight weeks, with their progress measured using the Hamilton Depression Scale, 6-item version (HDS-6). Throughout the study, participants will attend multiple in-person assessments and provide blood and urine samples, as well as participate in telephone interviews to monitor their symptoms and overall well-being.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* A diagnosis of bipolar disorder, type 1 or type 2, and a current episode of depression according to DSM-5
* Severity of depression: A score of at least 21 on the self-reported Major Depression Inventory (MDI).
* No start or dose increase of psychotropic medication (except for benzodiazepines and benzodiazepine-like drugs (zopiclone, zolpidem, and melatonin)) in the two weeks prior to inclusion.
* No new start of formalized psychotherapy sessions, excluding psychoeducation, during the 4 weeks prior to inclusion.
* Age criteria: Subjects must be at least 18 years old and below 65 at the time of randomization.
* The duration of the current depressive episode must be between 4 and 52 weeks as judged by the investigator at the time of randomization.
* Clinical uncertainty regarding which of the alternatives, cariprazine and lithium, would be the better choice in the specific case.
* Female participants should be sterile or non-fertile or, in case of being fertile, they must have a negative pregnancy test AND use safe anticonception.
* Signed document of informed consent.

Exclusion Criteria:

* Prior or ongoing acute treatment of a depressive episode lasting \> 14 days with either lithium or cariprazine as judged by the investigator.
* ECT within the current depressive episode.
* A score of MAS \> 6.
* A diagnosis of dementia.
* High risk of non-adherence at the investigator's discretion.
* Not understanding the Danish language as judged by the investigator
* Psychiatric coercion in the form of forced admission or detainment OR sentence to forensic psychiatric care.
* Presence of clinically relevant delusions, hallucinations or other psychotic symptoms as judged by the investigator.
* Suicidality according to C-SSRS with a positive response to question 4 or 5 or upon investigator's discretion.
* Medical conditions like cancer, kidney failure, epilepsy, deep brain stimulation device, or other medical conditions interfering with study the outcome and safety as judged by investigator's discretion.
* Current harmful use or dependency of alcohol or drugs according to DSM-5.
* Known allergy to any of the substances in the study medication.

Where it's running

• Aalborg University Hospital
  Aalborg, Denmark Recruiting

Study contacts

• Principal investigator: René E. Nielsen, Prof, MD,PhD — Psychiatry, Aalborg University Hospital
• Study coordinator: Sanne V. Hovgesen, MD
• Email: sanne.hovgesen@rn.dk
• Phone: +45 25487706

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Longitudinal look at how lasting TMS benefits can be predicted for depression

  This study follows people with major depressive disorder who responded to prior rTMS to see what factors predict how long their response lasts.

  Recruiting Hospital Center Guillaume Régnier · Rennes · NCT07684911

• Digital twins to classify mental health patterns in adults with diabetes

  This project will try to create 'digital twin' profiles that combine glucose, mood, and behavior data to track mental health patterns in adults with diabetes.

  Recruiting Forschungsinstitut der Diabetes Akademie Mergentheim · Bad Mergentheim, Baden-Wurttemberg and 2 other locations · NCT07212075

• Right-sided low-frequency (1-Hz) rTMS versus left-sided intermittent theta-burst stimulation for depression

  This trial will test whether right-sided low-frequency (1-Hz) rTMS works as well as left-sided iTBS for adults with unipolar or bipolar depression.

  Recruiting at 2 sites Phase 4 Region Örebro County · Örebro and 1 other locations · NCT07026461

• Assessing the safety and acceptability of psilocybin for Bipolar II depression

  This study is testing if giving two doses of psilocybin along with therapy can be a safe and helpful treatment for people with Bipolar II Disorder who are feeling depressed and suicidal.

  Recruiting Phase 2 The University of Texas Health Science Center, Houston · Houston, Texas · NCT06706232

• Understanding the impact of mood disorders and treatment responses

  This study is trying to learn more about how people with depression and bipolar disorder respond to treatment by talking to them weekly for up to 12 weeks to improve future care and predict how well medications might work.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06462196

• Bright Light Therapy for Depression

  This study tests if Bright Light Therapy can help people with unipolar and bipolar depression feel better, and whether adding lifestyle changes can make it work even better.

  Recruiting at 2 sites Universiteit Leiden · Eindhoven and 1 other locations · NCT05958940

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.